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1. Introduction   
Chronic chagasic cardiomyopathy (CCC) is the most serious manifestation of the chronic 
phase of Chagas’ disease and constitutes the most common type of chronic myocarditis in 
the world (Guerri-Guttenberg, et al., 2008, Milei, et al., 1996a, Milei, et al., 2009, Milei, et al., 
1992a, Storino, et al., 1992). Chagas’ disease, a chronic illness caused by the flagellate 
parasite Trypanosoma cruzi (T. cruzi), was first described in 1909 by the Brazilian physician 
Carlos Chagas (Chagas C, 1909). The insect vectors of the disease are present throughout 
most of South and Central America, and their zone of distribution extends across the 
southern United States (Rassi, et al., 2010). It was estimated by year 2000, that in endemic 
areas 40 million people were considered to be at risk of infection, being 20 million already 
infected. Every year near 200,000 new cases are expected to happen, and 21,000 deaths per 
year occur (WHO, 2005). 
Although always considered to be confined to Latin America, due to migratory movements 
from endemic countries to Europe and North America, Chagas’ disease is being detected 
more frequently in developed countries. Europe is estimated to have from 24,001 to 38,708 
(lower or upper limit of estimate, respectively) immigrants with T. cruzi infection (Guerri-
Guttenberg, et al., 2008).  In the United States, six autochthonous cases, five transfusion 
related cases and five transplant related cases have been reported, but migratory 
movements still remain the main source of Chagas’ disease. It has been estimated that 
around 89,221 to 693,302 infected Latin Americans migrated to the United States in the 
period 1981 to 2005 (Milei, et al., 2009). 
Two phases of the disease can be distinguished: (1) acute phase, with transiently high 
concentration of parasites in tissue and blood, nonspecific symptoms, and a 5% myocarditis 
incidence, lasting 4 – 8 weeks; and (2) chronic phase, lasting lifelong. Chronic phase can be 
presented as indeterminate form, characterized by lack of symptoms and normal ECG and 
normal radiographic examination of the chest, esophagus and colon. Approximately 60 – 
70% of patients remain in this form for the rest of their lives. Only 20-40% of infected 
individuals, 10-30 years after the original acute infection, will develop cardiac, digestive or 
mixed form of the disease, characterized by the appearance of megavicera (dilated 
cardiomyopathy, megaesophagus and/or megacolon). It poses a substantial public health 
burden due to high morbidity and mortality (Milei, et al., 2009, Rassi, et al., 2000, Rassi, et 
al., 2010). 
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CCC is manifested by a chronic, diffuse, progressive fibrosing myocarditis that involves not 
only the working myocardium but also the atrioventricular (AV) conduction system, 
autonomic nervous system and microcirculation (Andrade, 1985, Marin-Neto, et al., 2007, 
Milei, et al., 1991b). This leads to cardiomegaly, cardiac failure, arrhythmias, 
thromboembolism, and death (Milei, et al., 1991b). Colon and esophagus are also commonly 
affected by Chagas’ disease, being megacolon with constipation and megaesofagus with 
achalasia also features of the disease (Rassi, et al., 2010). 
2. Pathogenesis of Chagas’ myocarditis 
Milei et al. proposed a combined theory that could explain the pathogenic mechanism in 
chronic chagasic myocarditis (Milei, et al., 1996a, Storino & Milei, 1994). This theory is based 
on three ingredients: the parasite, host immune system and fibrosis. These ingredients are 
proposed as being the primary causative agents of damage on myocardial tissue, conduction 
system, autonomic ganglia and nerves and microvasculature. 
2.1 First ingredient: the parasite 
The role of T. cruzi in the chronic phase has been previously underestimated due to the fact 
that its presence was believed to be scarce and unrelated to the inflammatory infiltrate 
present at this stage. Nowadays, the involvement of the parasite in the chronic phase has 
been well documented. Using dissimilar methods, different authors demonstrated either the 
persistence of T. cruzi or parasite antigens in mice (Younées-Chennoufi, et al., 1988), the 
parasite DNA sequence amplified by the polymerase chain reaction (PCR) (Jones, et al., 
1993, Schijman, et al., 2004), T. cruzi antigens from inflammatory lesions in human chagasic 
cardiomyopathy (Higuchi, Brito et al. 1993), or the immunohistochemical finding of the 
parasite in endomyocardial biopsies with PCR confirmation (Añez, Carrasco et al. 1999). 
This would suggest a direct role for the parasite in the perpetuation of myocardial 
inflammation. In other words, the antigen stimulation would persist throughout the chronic 
stage, even though the parasites are not morphologically detectable by light microscopy 
(Andrade 1992).  
The role of parasitemia is more controversial. High parasitemia correlated with severity of 
disease in one report (Basquiera, et al., 2003), but showed no association in another (Castro 
C., et al., 2005). 
Interestingly, it has been observed that immunosuppression reactivates rather than 
ameliorates the disease, as seen in patients receiving immunosuppressive therapy to prevent 
transplant rejection and in AIDS patients. Accordingly, many experimental models where 
strains of genetically manipulated mice lacking various immune functions showed 
increased susceptibility to develop the disease (Tarleton & Zhang, 1999).  
2.1.1 Life cycle of Trypanosoma cruzi  
When a reduviid bug feeds from an infected mammal, it takes up circulating 
trypomastigotes, which reach then the bug’s gut. There, they differentiate to amastigotes, 
which proliferate and start to differentiate into epimastigotes. In this process, when 
amastigote is still sphere-shaped but has developed its flagellum, some authors call this 
stage spheromastigotes. Then, it elongates its cell body and flagellum, taking the classical 
epimastigote shape. At this stage, the parasite undergoes metacyclogenesis, differentiating 
in metacyclic trypomastigotes,  the infective form for mammals. When the bug feeds again, 
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it excretes trypomastigotes with feces, which in turn reach blood torrent through bug’s 
wound. Trypomastigotes can infect a wide variety of host cells, within them it differentiate 
into amastigotes and proliferate. Then, they can differentiate into trypomastigotes again, 
reach circulation and infect new cells. If an uninfected bug feeds from the animal in the 
moment of parasitemia, cycle starts again (Tyler & Engman, 2001).      
 
 
 
Fig. 1. Life cycle of Trypanosoma cruzi. 
2.1.2 Genetic variability of Trypanosoma cruzi and its relation to its pathogenesis 
The genetics of T. cruzi caught the attention of researchers in late 80’ and early 90’. First 
studies on variability were performed analyzing electrophoretic variants on cellular 
enzymes. The groups resulting were called zymodemes and were named Z1, Z2, Z3. Only 
Z2 was associated with domestic transmission cycle.  
The development of PCR based techniques, allowed the study of new variant regions  and 
the characterization of multiple variants of a great number of genes. All these variants 
showed significant correlation with each other, suggesting the existence of two subtypes of 
T. cruzi based on these data (Macedo, et al., 2004). Moreover, T. cruzi II which is clearly 
linked to human pathology, being T. cruzi I mainly related to infection of wild sylvatic 
mammals. Even, applying LSSP-PCR to the study of the variable region of kinetoplast 
minicircle from T. cruzi provided evidence of a differential tissue distribution of genetically 
diverse T. cruzi populations in chronic Chagas’ disease, suggesting that the genetic 
variability of the parasite is one of the determining factors of the clinical form of the disease 
(Vago, et al., 2000). 
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2.1.3 Cell host invasion and intracellular survival by Trypanosoma cruzi  
Once T. cruzi reaches blood torrent, it invades a great variety of cells in the host. When 
parasiting non phagocytic cells, T. cruzi uses some surface glycoproteins to attach to cell: 
gp82, gp30 and gp35/50. All three glycoproteins are known to induce calcium mobilization 
from intracellular reservoirs. Gp82 is linked to the phospholipase C (PLC) and inositol 1,4,5 
– triphosphate (IP3). Gp 35/50 is associated to increasing intracellular levels of cyclic AMP. 
On the other side, cruzipain, a protein known to be secreted by T. cruzi, acts on kininogen 
and produces bradykinin, which binds to its receptor, further increasing intracellular 
calcium. Increased intracellular calcium produces modifications in cytoskeleton that lead to 
parasite endocytosis (Yoshida & Cortez, 2008). 
In the parasitoforous vacuole, mainly by the action of gp85/TS a glycoprotein with trans-
sialidase action, and TcTox, a protease, the parasite degrades the membrane of the vacuole, 
escapes from it and proliferates within the cell (Alves & Colli, 2007). 
2.1.4 Molecular mimicry  
The induction of autoimmunity by similarities between T. cruzi and host epitopes has been 
long proposed as a mechanism that leads to tissue damage in the chronic phase of the 
disease. Both humoral and cellular autoimmune responses have been described, but we will 
discuss them in more detail in the section of immune system. The real importance of 
molecular mimicry in the pathogenesis of chagasic myocarditis is still a matter of debate 
(Girones, et al., 2005). 
Although it seems that in some cases this mechanism triggers autoimmunity, in many 
others, autoimmunity seems to be an epiphenomenon of cellular destruction, with 
exposition of intracellular epitopes not normally exposed to the immune system. This, in 
turn may activate autoreactive lymphocytes leading to the appearance of autoantibodies 
that are not the cause of damage, rather a consequence (Girones, et al., 2005). 
The most important cross reacting epitopes of T. cruzi and the correspondent epitopes in 
humans are listed in table 1, as well as the kind of immune response they elicit. 
2.2 Second ingredient: host immune system 
When the three ingredients theory was first proposed (Storino and Milei 1994, Milei, et al. 
1996), second ingredients were mainly T lymphocytes and macrophages. In the subsequent 
years some evidence grew about the participation of humoral immune system through 
autoantibodies in the pathogenesis. As a consequence, the whole immune system of the host 
is now considered as the second ingredient.  
As described earlier, mononuclear cells persist in the chronic stage of the disease, 
contributing to the inflammation through its products of secretion or through its own 
cytotoxicity (suppressor T cells) and cytolytic action (macrophages) (Storino & Milei, 1994). 
As previously stated, molecular mimicry may be the main explanation of autoimmunity, 
triggering both cellular and humoral autoreactivity (Girones, et al., 2005). Figure 2 
summarizes the most important immune events in CCC pathogenesis.  
2.2.1 Innate immunity 
In recent years innate immunity came to the attention of researchers of Chagas’ disease 
pathogenesis. The role of NK cells has been particularly studied in early and late 
indeterminate forms of the disease and in CCC patients. In early indeterminate patients, 
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Parasite antigen Human Antigen Immune reaction 
B13 Cardiac myosin heavy chain Autoantibodies 
Autoreactive T cells 
R13 (ribosomal protein) 
Ribosomal protein 
1-adrenergic receptor 
M2-muscarinic receptor 
38-kDa heart antigen 
Autoantibodies 
Ribosomal protein PO 1-adrenergic receptor Autoantibodies 
FL-160 47-kDA neuron protein Autoantibodies 
Shed acute-phase antigen 
(SAPA) 
Cha antigen Autoreactive T cells 
TENU2845/36 kDa Cha antigen Autoantibodies 
Calcireticulin Calcireticulin Autoantibodies Autoreactive T cells 
Galactosyl-cerebrosides Galactosyl-cerebrosides Autoantibodies 
Unknown Neurons, liver, kidney, testis Autoantibodies 
Sulphated glycolipids Neurons Autoantibodies 
150-kDa protein Smooth and striated muscle Autoantibodies 
Cruzipain 
Cardiac myosin heavy chain 
M2-muscarinic receptor 
Autoantibodies 
Microsomal fraction Heart and skeletal muscle Autoantibodies 
Cytoskeleton 95-kDa myosin tail Autoantibodies 
SRA 
Skeletal muscle Ca2+ dependent 
SRA 
Autoantibodies 
MAP MAP (brain) Autoantibodies 
Soluble extract Myelin basic protein 
Autoantibodies 
Autoreactive T cells 
55-kDa membrane protein 
28-kDa Lymphocyte membrane 
protein 
Autoantibodies 
Table 1. Examples of cross-reacting epitopes (Girones, et al., 2005, Marin-Neto, et al., 2007). 
compared to non infected people, increased values of pre-natural killer (NK)-cells (CD3- 
CD16+ CD56-), and higher values of proinflammatory monocytes (CD14+ CD16+ HLA-DR++) 
were found. The higher values of activated B lymphocytes (CD19+ CD23+) contrasted with 
impaired T cell activation, indicated by lower values of CD4+ CD38+ and CD4+ HLA-DR+ 
lymphocytes, a lower frequency of CD8+ CD38+ and CD8+ HLA-DR+ cells; a decreased 
frequency of CD4+ CD25HIGH regulatory T cells was also observed. All these data suggest a 
rather proinflammatory profile (Vitelli-Avelar, et al., 2006). This profile may be useful to 
limit parasitemia and confine infection to tissues. In fact, it has been demonstrated that NK 
cells are important in defense against the spread of parasitic infection (Brener & Gazzinelli, 
1997), and are an important source of INF-a key cytokine to activate macrophages and 
help with parasite clearance (Camargo, et al., 1997). 
In late indeterminate form, CD3-CD16+CD56+ and CD3-CD16+CD56DIM NK cells are 
increased but are in normal range in CCC patients, suggesting a protective role for them 
(Vitelli-Avelar, et al., 2005). NK cells showing CD56DIM may play a role in the down 
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modulation of cytotoxic deleterious T CD8+ response reported in CCC patients (Sathler-
Avelar, et al., 2009). 
Monocytes display different cytokine profile. In indeterminate patients they produce more 
IL-10 (Gomes, et al., 2003) while in CCC patients they produce more TNF- (Vitelli-Avelar, 
et al., 2008), leading to a proinflammatory profile that could be responsible for chronic 
myocarditis. 
Toll-like receptors (TLR) are also implied in the response to acute infection with T. cruzi. 
TLR-2 has been shown to recognize GPI surface molecules from the parasite. In vitro and in 
vivo studies have demonstrated that macrophages stimulated with GPIs through TLR-
2/CD14 receptors produce NO, TNF- and IL-12 (Campos & Gazzinelli, 2004).   
2.2.2 Cellular adaptative immunity 
The role of immune cells in the pathogenesis of Chagas’ heart disease has been the dominant 
hypothesis for many years. The paucity of parasite cells in the inflamed myocardium and 
the presence throughout the evolution of the disease of macrophages and lymphocytes in 
patched infiltrates lead to this hypothesis. As early as in 1929, Magariños Torres, observing 
those infiltrates postulated an “allergic” mechanism for CCC. Further, Mazza and Jörg 
followed this thought and supported the “allergic” theory (Storino & Milei, 1994). 
The study of circulating lymphocytes in peripheral blood of chagasic patients showed an 
increase in the percentages and actual numbers of double-positive cells of the phenotype 
CD3+/HLA-DR+, as well as decrease in the percentage of CD45RA+/CD4+ and 
CD45RA+/CD8+ T cells, indicating greater numbers of activated T cells circulating. 
Consistent parallel increases were seen also in the B lymphocyte subset which stained 
double-positive for CD19/CD5 (Dutra W. O., et al., 1994). These results were similar for 
both indeterminate and CCC patients. Moreover, activated T cells lacking the co-stimulatory 
molecule CD28 are increased in chagasic patients (Menezes, et al., 2004) and express high 
levels of HLA-DR molecules (Dutra, et al., 2000). Some interesting differences were 
demonstrated between indeterminate and CCC patients. CD28- T cells in indeterminate 
patients showed expression of CTLA-4, which recognizes the same ligands as CD28, but 
instead of inducing cell activation it causes down modulation of T cells. On the contrary, T 
cells in CCC patients do not up-regulate CTLA-4 (Souza P. E. A., et al., 2007). It is 
particularly interesting that CD8+CD28- cells are increased in CCC patients compared to 
indeterminate patients, and that these cells do not require co-stimulation to exert their 
cytotoxic functions. More strikingly, CD4+CD28- cells behave differently in indeterminate 
and CCC patients. In the formers, they are closely related to IL-10 levels, while in CCC 
patients they correlate with INF- levels (Menezes, et al., 2004). 
Another interesting difference has been found in cellular response between indeterminate 
and CCC patients. CD4+ cells from CCC patients had an increased expression of V5+-TCR, 
not found in indeterminate patients. When CCC patients mononuclear cells from peripheral 
blood were cultured in the presence of trypomastigotes antigens, a selective expansion of 
CD4+ V5+ cells was obtained; while when cultured in the presence of epimastigotes 
antigens, an expansion of CD8+ V5+ cells was also noted. These findings could not be 
repeated in indeterminate patients. Trypomastigote stimulation led to the expansion of 
CD4+ V17+ in indeterminate patients, not seen in CCC patients. This suggests that CCC 
patients and indeterminate patients respond to different antigen repertoires (Costa, et al., 
2000). 
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Monocytes from indeterminate patients, when infected in vitro with T. cruzi, express low 
levels of HLA-DR and high levels of CD80, a ligand for CTLA-4 (Souza P. E., et al., 2004). 
The interaction of these monocytes with CTLA-4+ T cells leads to the expression of IL-10, a 
cytokine known to down-modulate inflammatory responses (Gomes, et al., 2003). This is not 
observed in CCC patients. CD28- T cells, not expressing CTLA-4, express TNF- and INF- 
(Menezes, et al., 2004). 
In the same direction, CD4-CD8-  T cells are found to be increased in indeterminate 
patients compared with CCC ones. These cells are also linked to the production of IL-10 and 
a down modulator effect on inflammation (Villani, et al., 2010). 
Cells infiltrating myocardium have also been studied. As demonstrated with 
immunostaining of endomyocardial biopsies by our group, leukocytes infiltrating 
myocardium in Chagas’ disease were approximately 50% macrophages, and 50% 
lymphocytes, mainly T lymphocytes (Milei, et al., 1992b). Further immunohistochemical 
characterization of these cells with CD45R for lymphocytes, CD20 and  lambda and kappa 
light chains for B lymphocytes, CD45R0 for T lymphocytes and CD68 for macrophages, 
confirmed these findings (Milei, et al., 1996a).  
Autoreactive T cells have caught the attention of many investigators. In experimental 
models, CD4+ T cells from infected mice showed a proliferative response to the exposition to 
human cardiac myosin heavy chain and to T. cruzi B13 protein. They also arrested the 
beating of fetal heart cells and, more importantly, induced myocarditis in immunized mice 
and promoted rejection of transplanted normal hearts in the absence of T. cruzi (Ribeiro-
Dos-Santos, et al., 2001). Also, it has been described that T cells infiltrating the  myocardium 
of chagasic patients cross react with human cardiac myosin heavy chain and to T. cruzi B13 
protein and express high levels of INF- and low levels of IL-4, switching to a Th1 profile 
(Cunha-Neto Edecio & Kalilf, 2001).  
In recent years, Treg cells have come to attention in relation to Chagas’ disease 
pathogenesis. These cells are characterized by the expression of CD4, CD25 and FOXP3 
(Ziegler & Buckner, 2009). Treg cells are increased in indeterminate patients compared to 
CCC, which correlates negatively with levels of activated CD8+ (Vitelli-Avelar, et al., 2005). 
A second subset of T CD4+ cells, recently described, the Th17 cells, resulted important in 
Chagas’ disease pathogenesis. These cells, mainly linked to autoimmune pathology, are 
characterized by the expression of CD4+, RORt, and secrete IL-17 (Di Jin, et al., 2008). They 
were increased in a murine model of acute myocarditis induced by T. cruzi infection, as well 
as by immunization with heat-killed T. cruzi antigens (Bonney, et al., 2011). Both cell subsets 
seem to be related, as they require TGF- to differentiate. In the presence of 
proinflammatory cytokines, differentiation to Th17 cell prevails and a pro-autoimmune 
profile develops (Ziegler & Buckner, 2009).  
An additional mechanism is the bystander activation. This is the activation of autoreactive 
lymphocytes by antigen presenting cells in a proinflammatory environment (Fujinami, et al., 
2006). This kind of autoreactive T cells activation has been described in Chagas’disease 
(Fedoseyeva, et al., 1999). 
2.2.3 Humoral adaptative immunity 
The importance of humoral immunity in controlling T. cruzi acute infection has been clearly 
established. Mice lacking B lymphocytes rapidly succumb to infection (Kumar & Tarleton, 
1998). But the fact that attracted most attention is the production of autoantibodies.  
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Fig. 2A. The immune pathogenesis of Chagas disease in indeterminate patients. The 
presence on numerous down regulating mechanisms shift the response towards an anti-
inflammatory profile. 
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Fig. 2B. The immune pathogenesis of Chagas disease in CCC patients. Cells evolve towards 
a proinflammatory profile, with development of autoimmunity. 
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The first autoantibody to be described was one that reacted to endocardium, blood vessels 
and interstitium of skeletal muscle (EVI) (Cossio, et al., 1974), but was the same group of 
investigators who recognized the heterophil nature of the antibody and realized that had no 
pathogenic role (Khoury, et al., 1983). 
Another autoantibody, studied by our group, was anti-laminin antibody (Sanchez, Milei et al. 
1993, (Milei, et al., 1993). These antibodies were shown to react against T. cruzi amastigotes and 
trypomastigotes and human laminin (Szarfman, et al., 1982) and deposition of this antibody in 
marked thickened basement membranes of myocytes, endothelial cells, and vascular smooth 
muscle cells was shown by us with light microscopy, electron microscopy and 
immunohistochemical techniques in endomyocardial biopsies of chagasic patients (Sanchez, et 
al., 1993) but then we found that only 50% of patients had the antibody on their sera and no 
correlation with disease severity could be established (Milei, et al., 1993). 
Anti-myosin antibodies were postulated by some authors to be generated through 
molecular mimicry with two T. cruzi antigens: B13 protein (Gruber & Zingales, 1993) and 
cruzipain (Giordanengo Laura, et al., 2000a, Giordanengo Laura, et al., 2000b). Although 
cruzipain antibodies mainly react to skeletal muscle myosin, they can cause conduction 
disturbances when transferred to uninfected mice and, when transferred to pregnant 
animals, they caused conduction disturbances in pups (Giordanengo Laura, et al., 2000b). 
On the other hand, immunossuppresed mice did not mount any humoral response when 
immunized with myosin but still develop myocarditis (Neu, et al., 1990). This fact made 
some authors doubt on the molecular mimicry hypothesis and rather consider antibodies to 
myosin a consequence of myocyte damage (Kierszenbaum, 2003). 
Antibodies that react with muscarinic receptors were intensely studied. In early 1990’s IgG 
from chagasic patients was observed to bind to muscarinic M2 receptors and activate them 
(Sterin-Borda L, et al., 1991). These anti-muscarinic antibodies were found to increase 
intracellular cGMP and decrease cAMP (Goin J., et al., 1997) and were positively related to 
the presence of dysautonomia (Goin J. C., et al., 1994). These antibodies also caused 
accumulation of inositol phosphate and nitric oxide synthase stimulation, with a negative 
inotropic effect on myocardium (Sterin-Borda Leonor, et al., 1997). As mentioned before, 
anti-muscarinic autoantibodies are positively related to the presence of dysautonomia (Goin 
J. C., et al., 1994), the presence of achalasia in chagasic patients (Goin J. C., et al., 1999), sinus 
node dysfunction (Altschuller, et al., 2007), but are not related with the degree of myocardial 
dysfunction (Altschuller, et al., 2007, Talvani Andre, et al., 2006), nor with the presence of 
brain lesions (Py, et al., 2009). In fact, patients with cardiomyopathy and left ventricular 
dysfunction but without autonomic dysfunction show low levels of anti-muscarinic 
antibodies (Sterin-Borda Leonor & Borda, 2000). 
Antibodies against 1-adrenergic receptors were also deeply studied. Described in early 
1980’s (Borda E., et al., 1984) these antibodies increased cAMP in mouse atrial fibers, 
increasing the release of PGE2 and TXB2 causing diminished contractility (Gorelik, et al., 
1990). Increased cAMP activates PKA and then increases the intracellular calcium 
concentration. This causes in turn inhibition of the Na+/K+-ATPase and stimulates Ca2+-
ATPase activity leading to intracellular depletion of K+ and further increase in Ca2+. These 
alteration alter contractility and electric impulse generation and conduction (Borda E. S. & 
Sterin-Borda, 1996). Antiadrenergic autoantibodies titers could not be related to the severity 
of left ventricular dysfunction (Talvani Andre, et al., 2006) and patients with overt 
cardiomyopathy but without autonomic dysfunction show low levels of these antibodies 
(Sterin-Borda Leonor & Borda, 2000). Antibodies against 2-adrenergic receptors have also 
been described but are mainly related to megacolon (Wallukat, et al., 2010). 
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Autoantibody Hypothetic pathogenic role Reference 
Anti-Cerebroside 
Probably related to neurologial 
symptoms 
(Avila & Rojas, 1990) 
Anti-Gal Apparently protective (Gazzinelli, 1991) 
Anti-Brain 
Microtubules 
Unknown (Kerner, et al., 1991) 
Anti-Ribosome Unknown 
(Levitus, et al., 1991, 
Skeiky, et al., 1992) 
Anti- UsnRNPs Unkwnown 
(Bach-Elias, et al., 
1998) 
Anti-Sulfatides 
May cause myocarditis and induce 
arrhythmias 
(Garcia, et al., 1998) 
Anti-Galectin-1 Increased in CCC patients 
(Giordanengo L., et al., 
2001) 
Anti-Cha R3 Specific of CCC (Girones, et al., 2001a) 
Anti-Desmoglein-1 Related to Penphigus foliaceum (Diaz, et al., 2004) 
Anticardiolipin Unknown 
(Pereira De Godoy, et 
al., 2005) 
Anti- TrkA, TrkB 
and TrkC 
Prevents apoptosis of neurons and helps 
cellular invasion 
(Lu, et al., 2010) 
Anti-MBP Related to gastrointestinal form 
(Oliveira E. C., et al., 
2009) 
Table 2. Less studied autoantibodies in Chagas’ disease. 
Antibodies against AV node and sinus auricular node tissues have been studied as markers 
of CCC. When compared in chronic chagasic cardiopathy patients, non-chagasic 
cardiopathy patients, indeterminate chagasic subjects and healthy blood donors as controls, 
they more frequently found in chronic chagasic cardiopathy, but not enough to be good 
markers for chagasic cardiopathy group. Besides, no clear association with complex rhythm 
or conduction alterations was found (Arce-Fonseca, et al., 2005). 
Many other autoantibodies have been described (table 2) but are not so widely studied and 
their role in pathogenesis of chagasic myocarditis is not clear. 
2.2.4 Genetic factors 
Human leukocyte antigens (HLA) have shown some relation to the development of CCC. 
HLA-B40 and Cw3 combination was protective for CCC (Llop, et al., 1991), as resulted 
DRB1*14, DQB1*0303 (Fernandez-Mestre, et al., 1998), HLA-DQB1*06 (Deghaide, et al., 
1998) and HLA-A68 (Cruz-Robles, et al., 2004). On the other hand, HLA-C*03 (Layrisse, et 
al., 2000), DRB1*1503 (Garcia Borras, et al., 2009), DRB1*01, DRB1*08, DQB1*0501 
(Fernandez-Mestre, et al., 1998) and HLA-DR16 alelles (Cruz-Robles, et al., 2004) were 
positively related to the development of CCC. 
A number of other genes related to immune system have been studied in order to determine 
their relation to a predisposition to develop CCC. In table 3 we list those positively related 
to the appearance of CCC (Cunha-Neto E., et al., 2009). 
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Gene Polymorphism 
CCL2/MCPI - 2518 
CCR5 + 53029 
TNF- - 308 
LTA + 80, + 252 
BAT-1 - 22, - 348 
NFkBIL-1 - 62, - 262 
IL-1B - 31, + 3954, + 5810 
IL-10 - 1082 
IL-12B + 1188 
MAL/TRIAP S180L 
Table 3. Genetic polymorphisms related to CCC. Adapted from (Cunha-Neto E., et al., 2009). 
2.2.5 The cytokines and chemokines 
Although proinflammatory cytokines seem to be necessary for controlling parasitemia 
during acute phase of the disease (Cunha-Neto E., et al., 2009), CCC patients display a rather 
proinflammatory cytokine while indeterminate patients display a down modulator one. 
CCC patients had higher levels of TNF- and CCL2 than indeterminate patients (Ferreira, et 
al., 2003, Talvani A., et al., 2004). Infiltrating macrophages from CCC patients expressed 
INF-, TNF- and IL-6 but showed low levels of IL-2, IL-4 and IL-10 (Abel, et al., 2001, Reis 
D. D., et al., 1993, Reis M. M., et al., 1997). Also CCR5, CXCR3 and CCR7 and their ligands 
were increased in hearts of CCC patients, as well as monocytes expressing CXCR3, CCR5, 
CXCL9 and CCL5 (Cunha-Neto E., et al., 2009). It has been shown that INF- and CCL2 
induceed myocytes to secrete arial natriuretic factor and caused hypertrophy (Cunha-Neto 
E., et al., 2005), and IL-18 and CCR7 ligands, which are increased in CCC, caused 
cardiomyocyte hypertrophy and fibrosis (Reddy, et al., 2008, Riol-Blanco, et al., 2005, Sakai, 
et al., 2006). 
2.3 The third ingredient: fibrosis 
Fibrosis is one of the most striking characteristics of CCC. In our patients with CCC in 
endomyocardial biopsies, fibrosis had replaced between 8.2 and 49% of contractile 
myocardium, with only one patient having less than 10% (Milei, et al., 1992b). While in 
autopsies, fibrosis was more extensive reaching in the conduction system than in the 
contracting myocardium (51.5 ± 18% vs 43.4 ± 8%, p < 0.05) (Milei, et al., 1996a). 
The deposition of laminin in extracellular and basement membranes has been implicated in 
the pathogenesis of inflammatory process, as laminin is able to bind proinflammatory 
citokines (Savino, et al., 2007). The inflammatory infiltrate in CCC was related to the 
production of citokines such as INF-, TNF-, IL-18, CCL2 and CCL21, that may have 
modulator actions on fibrotic process (Cunha-Neto E., et al., 2009).   
3. A combined theory that could explain the pathogenic mechanism in 
chronic chagasic myocarditis 
With the perpetuation of inflammation, necrosis and scarring fibrosis, damage to all 
histological components of myocardium occurs. Damage to contracting myocardial fibers 
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determines contractile failure as well as electrophysiological disturbances. Conduction 
system, nervous autonomic system and microvasculature are also damaged and as a 
consequence they cause further damage to contractile myocardium and produce electrical 
instability. Figure 3 illustrates with a flow chart the interactive network of different elements 
in the pathogenesis of CCC. 
 
 
Fig. 3. Schematic representation of the integrated theory of multiple factors that determine 
myocardial damage in CCC. 
4. Pathophysiological consequences of organ damage 
4.1 Dysautonomia 
As early as 1922 Carlos Chagas noted that the chronotropic response to atropine was altered 
in chagasic patients (Chagas C. & Vilella, 1922), but it was not until late 1950’s that Köberle 
published his works showing impressive neuronal depopulation in microscopic sections 
obtained from the intercaval atrial strip in chagasic patients using a standardized technique 
of cardiac intramural neuronal counting developed by himself (Köberle, 1956a, 1956b). 
These findings led to the “neurogenic hypothesis” (Köberle, 1959), which explained all 
megas in Chagas’ disease as a consequence of neuronal depletion. 
Although many other authors claimed to have confirmed this finding (Mott & Hagstrom, 
1965, Oliveira J. S., 1985), other authors called to attention about the criteria used to 
diagnose neuronal depletion because of the great variability in the number of neurons in 
autonomic ganglia (Rossi L., et al., 1994) and they also remarked that the only right criterion 
to establish neuronal depletion is the presence of proliferation of satellite cells, with the 
formation of Terplan’s nodules, a characteristic lesion described as proliferating satellite 
cells which replace degenerating neurons, forming nodular structures. These lesions, once 
considered patognomonic, can be found in other cardiomyopathies (Rossi L., et al., 1994). 
The same author could not confirm the loss of neurons or denervation in CCC (Rossi L., 
1988). Finally, it was demonstrated that, using Terplan’s nodules as diagnostic criterion, 
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CCC patients with heart failure had more neuronal depletion than patients with dilated 
cardiomyopathy of other causes (Oliveira J. S., 1985). In our experience the neuroganglionic 
involvement was variable in autopsies of chagasic hearts (Milei, et al., 1991b). 
According to pioneer neurogenic hypothesis (Köberle, 1959), early and irreversible damage 
to the parasympathetic system during acute phase of the disease causes a cathecolaminergic 
cardiomyopathy, but this point of view has been debated and evidence is contradictory. 
Functional test performed in CCC patients demonstrated impaired parasympathetic heart 
rate regulation (metaraminol, phenylephrine and atropine intravenous injections, facial 
immersion, Valsalva maneuver, head-up and head-down tilt tests, respiratory sinus 
arrhythmia, handgrip, graded dynamic exercise, and spectral analysis of Holter recordings) 
(Amorim, et al., 1968, Amorim, et al., 1973, Gallo, et al., 1975, Guzzetti, et al., 1991, Junqueira 
Junior, et al., 1985, Manço, et al., 1969, Marin-Neto, et al., 1975, Sousa, et al., 1987). However, 
a careful analysis of these data showed that many patients had normal autonomic function 
and most patients had heart failure, that could explain autonomic dysfunction per se (Davila, 
et al., 1998).  
On the other hand, the study of indeterminate patients has shown conflicting results. While 
some authors could demonstrate impaired autonomic function (Molina, et al., 2006, 
Vasconcelos & Junqueira, 2009) others could demonstrate that autonomic function was 
normal in patients without myocardial damage and that abnormalities in autonomic 
dysfunction was proportional to heart dysfunction, leading these authors to propose that 
these abnormalities arise as a compensating mechanism for the progressive left ventricular 
dilatation (Davila, et al., 1991, Davila Spinetti, et al., 1999). These findings led to a new 
“neurogenic theory”, which considers autonomic dysfunction as secondary to ventricular 
dilatation and hemodynamic alterations, but once installed, acts synergistically with 
parasitism and inflammation to cause further myocardial damage (Davila, et al., 2004). 
4.2 Microvascular damage 
Microcirculation abnormalities in CCC have been firstly pointed out by Jorg as an 
angiographic anarchy due to  capillary loss (Jörg, 1974) and furtherly demonstrated in 
experimental models as well as in clinical practice (Rossi M. A., et al., 2010). 
Many investigators have found abnormal myocardial perfusion using isonitrile-99m-
technetium (Castro R., et al., 1988) and thallium-201 (Hagar & Rahimtoola, 1991, Marin-
Neto, et al., 1992) scintigraphy in chagasic patients with normal epicardial coronary arteries. 
Furthermore, the progression of left ventricular systolic  dysfunction is associated with both, 
the presence of reversible perfusion defects and the increase in perfusion defects at rest 
(Hiss, et al., 2009, Schwartz & Wexler, 2009). Anatomopathological studies in humans also 
provided evidence of  microvascular damage in CCC. In late 1950’s first reports showing 
collapse of arterioles and intimal proliferation (Torres, 1960) caught the attention of 
investigators. Also, microthrombi have been described (Rossi M. A., et al., 1984). As said, in 
endomyocardial biopsies thickening of capillary basement membranes was also found 
(Milei, et al., 1992b). 
Additional evidence of microvascular damage was obtained from experimental models. 
Vascular  constriction, microaneurysms, dilatation and proliferation of microvessels has 
been demonstrated (Factor & Sonnenblick, 1982, Morris, et al., 1989, Tanowitz H. B., et al., 
1996, Tanowitz Herbert B., et al., 1992b). 
Many factors have been advocated in the genesis of these lesions. First, the parasite itself. It 
was shown that T. cruzi produces a neuraminidase that removes sialic acid from de surface 
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of endothelial cells. This results in thrombin binding and platelet aggregation (Libby, et al., 
1986). T. cruzi also produces tromboxane A2 (TXA2), specially during amastigote state 
(Ashton, et al., 2007), also favouring platelet aggregation and vascular spasm. Direct 
parasitism of endothelial cells by T. cruzi has also been demonstrated, and this causes the 
activation of the NF-B pathway increasing the expression af adhesion molecules (Huang, et 
al., 1999a), and secreting proinflammatory citokines (Tanowitz Herbert B., et al., 1992a) and 
iNOS (Huang, et al., 1999b). 
Endothelin-1 (ET-1) is another proposed pathogenic element. Elevated levels of mRNA for 
preproendothelin-1, endothelin converting enzyme and endothelin-1 were observed in the 
infected myocardium (Petkova Stefka B., et al., 2000), and elevated levels of ET-1 have been 
found in CCC patients (Salomone, et al., 2001). Mitogen-activated protein kinases and the 
transcription factor activator-protein-1 regulate the expression of endothelin-1, and both are 
shown to be increased in myocardium, interstitial cells and vascular and endocardial 
endothelial cells (Petkova S. B., et al., 2001). Besides, treatment with phosphoramidon, an 
inhibitor of endothelin converting enzyme, decreases heart size and severity of lesions in an 
experimental model of Chagas’ disease (Jelicks, et al., 2002). 
Inflammation also produces dysfunction of endothelial cells. Macrophages secrete TXA2 and 
platelet activating factor (PAF) act on endothelium causing vasoconstriction (Rossi M. A. & 
Carobrez, 1985). Endothelial cells infected in vitro with T. cruzi lose their antithrombotic 
properties in response to interleukin 1  (IL-1) (Bevilacqua, et al., 1984, Nachman, et al., 
1986). 
It is remarkable that, although the data presented, endothelial function seems to be normal 
in CCC patients without heart failure, as measured by increases in blood flow in response to 
acetylcholine and sodium nitroprusside (Consolim-Colombo, et al., 2004). Further, in our 
concept, microvascular damage found in CCC, seems to be secondary to fibrosis and 
distortion of myocardial fiber arrangement by necrosis and chronic infiltrates, but as once 
established, may contribute to the perpetuation of myocardial damage. 
5. Pathology 
Pathological findings are described mostly according to our own findings. 
5.1 Macroscopic features 
The most striking characteristic of CCC is enlargement of heart with variable degrees of 
dilatation of chambers (Andrade, 1985) (Figure 4A). In autopsy series, hearts were 
overweighted (Andrade, 1985, Baroldi, et al., 1997, Bestetti, et al., 1993, Lopes, et al., 1981) 
compared with indeterminate chagasic patients and non-chagasic subjects. Marked 
cardiomegalies reached up to 500 grams. Right ventricle (RV) and atrium (RA) were 
generally more compromised than left chambers, being RV the most dilated in one paper  
(Laranja, et al., 1956) but RA was in other (Andrade, 1985). 
A second remarkable feature is the thinning of the left ventricular apical wall, resulting in 
apical aneurysm, a very characteristic lesion in CCC (Figure 4B) (Moia, et al., 1955). 
Other lesions described are flattening of the papillary muscles and a marked subendocardial 
sclerosis, parietal and/or aneurismal thrombosis and fibrotic plaques in pericardium (Milei, 
et al., 1996a, Milei, et al., 1991b, Storino & Milei, 1994). 
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Fig. 4. A. High grade heart dilatation. Thining of the apical wall of the left ventricle (white 
arrow) and cavitary thrombus (black arrow). B. Characteristic apical aneurysm. A from 
Milei, et al., 1996b, B from Milei, et al., 2008. 
5.2 Histological features 
Microscopically, myocardial lesions consisted of a chronic inflammatory process with 
fibrotic scars and extensive mononuclear infiltrates. Such infiltrates were more prominent in 
the working myocardium and in the specialized cells of the left branch of the His bundle 
than in the AV node and in the right hisian branch, showing a microfocal disposition (Figure 
5A). The percentage of fibrosis was variable and ranged between 8.2 to 49% (Milei, et al., 
1996a, Milei, et al., 1992b) (Figure 5B).  
Extensive myocytolysis and spotty contraction band necrosis were observed. Cell 
hypertrophy in the apparently preserved myocytes was revealed by hypertrophic bizarre 
nuclei. Dilated lymphatic channels widespread in the ventricular septum and in the AV 
node, His bundle, and in the root of the right and left bundles branches were observed. In 
the case of apical aneurysm of the left ventricle, dilated lymphatic were distributed 
subepicardically (Milei, et al., 1996a).  
The serial sectioning of the conducting system showed prominent lesions. Sino-atrial node 
presented mononuclear infiltrates, necrosis of specialized fibers, and intense fibrosis (Milei, 
et al., 1991b). In the remaining specialized system lesions  consisted of mild to moderate 
diffuse fibrosis of the AV node and of the penetrating and branching portions of the His 
bundle, complete destruction of the proximal segments of the right and left bundles branch 
by varying degrees of replacement by dense collagen tissue (Figure 5A). The remaining 
specialized fibers presented atrophy and mild fatty infiltration and were surrounded in 
most cases by infiltrates consisting mainly of lymphocytes and macrophages. The 
subendocardial Purkinje fibers were usually damaged by chronic inflammation and fibrosis 
(Milei, et al., 1991b) (Figure 5B). These vast fibrosis in the conduction system (Figure 5C) 
showed severe conduction alterations in electrocardiograms, although curiously in one 
revision, there were needed sophisticated electrophysiological studies to demonstrate 
electrical abnormalities in these patients (Andrade, et al., 1988) 
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Fig. 5. A. Extensive mononuclear infiltrates, myocytes loss, and subendocardial fibrosis. 
Hematoxylin and eosin stain, X25. B. Atrophic myocardial fibres (red) separated by thick 
bands of fibrous tissue (blue). Mallory trichrome, X 25.  C. Bifurcating His bundle showing 
severe fibrosis at the left branch (between arrows). The right branch (asterisk) is 
intramyocardial and surrounded by connective tissue. Mallory trichrome, X25. A and C 
from Milei, 1996a. B from Milei, 2008. 
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Fig. 6. A. Detail of the left bundle of His is shown. Immunostaining for T lymphocyte. 
Positive cells express CD45R0 antigen (brown); specialized myocardial cells have almost 
disappeared. Extensive mononuclear infiltrate, the majority of them being T lymphocytes. 
X20. B. Double immunostaining for the simultaneous demonstration of T lymphocytes 
(CD45RO) and macrophages (CD68). T lymphocytes (brown) in close contact with a 
macrophage (pinky cytoplasm). X1000. C. Immunostaining to show endothelial cells. 
Capillaries and small vessels are clearly showed by the expression of CD31. Vessels are 
midly or moderately disorted because of the surrounding fibrosis. X100. From Milei, 1996a. 
In our studies in endomyocardial biopsies, infiltrates were approximately 50% lymphocytes 
and 50% macrophages. Almost 80% of   lymphocytic population were T lymphocytes, being 
only 20% B lymphocytes. Eosinophils were scarce in infiltrates reaching 5%, and were 
associated with areas of necrotic myocardium. Mast cells also were scarce or absent in 
specialized and in contracting myocardium. (Milei, et al., 1996a, Milei, et al., 1992b) 
Histological study of aneurisms showed a thinned wall 2-4 mm, with sclerotic plaques of 
thickened  endocardium of up to 92% of total tissue and extensive  mononuclear chronic 
inflammatory infiltrates and  widespread fibrosis in myocardium. Myocytes were 
organized in thin bands or atrophic units surrounded by fibrotic tissue (Figure 5B) (Milei, 
et al., 1991a). 
Autonomic ganglia showed above described Terplan’s nodules, with satellite cell 
proliferation replacing degenerated autonomic neurons. As stated, these lesions, once 
considered patognomonic, can be found in other cardiomyopathies (Rossi L., et al., 1994).  
5.3 Immunohistochemical findings 
Immunophenotyping of infiltrates allowed a better characterization of the cells participating 
in the inflammatory infiltrates, mainly macrophages (CD68+) and lymphocytes (CD45R+). In 
our works 26.5% percent of them were T lymphocytes (CD45R+, CD45R0+)  and 10.5% were 
B lymphocytes (CD20+, light chains kappa and/or lambda+) (Figure 6A). Thirty percent of 
the infiltrate was composed of macrophages (CD68+). The remaining infiltrate was 
composed of mononuclear cells resembling macrophages and CLA-negative mononuclear 
cells. Contacts between CD68 positive cells and T lymphocytes were frequently found 
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(Figure 6B). CD31 antibodies clearly pointed out normal endothelial cells, in either normal 
or damaged vessels (Figure 6C) (Milei, et al., 1996a). 
5.4 Ultrastructural features 
Myocardial fibers showed  nuclear enlargement, nuclear membrane invaginations, 
lipofuscin deposits, myofibrils derangements and loss, swelling, mitochondrial atrophy,  
dilatation of sarcotubular system, and interstitial fibrosis (Carrasco, et al., 1982, Palacios-Prü, 
et al., 1982). These findings have been confirmed by our group in endomyocardial biopsies 
(Ferrans, et al., 1988, Milei, et al., 1992b). Platelet thrombi can be demonstrated within 
capillaries (Figure 7B). 
Other striking alteration in these specimens was the thickening of the basement membranes 
of cardiac myocytes (Figures 7A, 7C), endothelium Figure 7C) and vascular smooth muscle 
up to 20 times their normal thickness of 500 Å (Ferrans, et al., 1988). The thickened basement 
membranes appeared structurally homogeneous, without being multilayered or subdivided 
into a lamina rara and a lamina densa. They were of relatively low electron density, had a 
finely fibrillar appearance at high magnification and measured up to 1 m in thickness. 
Using gold-conjugated antibodies, we could demonstrate the presence of laminin in the 
thickened basal membranes of myocytes and endothelium (Sanchez, et al., 1993). 
Regarding the ultrastructure of aneurysms resected from chagasic patients we observed, 
hypertrophy of myocytes, with swelling, partial or complete loss of myofibrils, swelling of 
mitochondria, disruption of mitochondrial cristae, lipofuscin granules, and  intact 
sarcolemmas . Basement membranes were thickened, as previously described (Milei, et al., 
1991a) 
 
 
 
        
 
 
Fig. 7. A. Myocardial fibre with thickened basement membrane. B. Platelet thrombus within 
a capillary. C. Thickened basement membranes in a myocardial fibre and a capillary. From 
Milei, et al., 2008. 
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6. Conclusions 
As shown across the sections of this chapter, the numerous hypothesis about pathogenic 
pathways of CCC have supporting data and pitfalls. Finally all  proposals interact with each 
other, giving us the idea that none of these theories explains the very complex development 
of CCC by itself. Rather, it seems more feasible that all  these hypothesis conform a network 
of damaging elements, and that all ingredients cause and/or enhances each other. The 
triggering factor is obviously the interaction between parasite and host’s immune system. 
Cell parasitism, the inflammatory process and consequent necrosis and fibrosis cause 
damage to contracting myocardium, autonomic system, conduction system and 
microcirculation. Autonomic damage causes impaired regulation of microvasculature and 
further alterations in blood flow. Ischemia causes more myocardial damage. Necrosis 
exposes intracellular epitopes and causes autoantibodies production with more necrosis, 
fibrosis and so on. It seems that, if adequate down modulator immune mechanisms work 
properly, this vicious circle stops and patients do not develop cardiomyopathy, rather they 
remain in the indeterminate form lifelong. 
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